Interferon-gamma Inducible Protein 10-biomarker for treatment outcome in chronic hepatitis C

被引：0

作者：

Sultana, Camelia ^{[1
,2
]}

Oprisan, Gabriela ^{[3
]}

Grancea, Camelia ^{[2
]}

Teleman, Monica Delia ^{[4
]}

Oprea, Cristiana ^{[5
]}

Florescu, Simin ^{[5
]}

Dinu, Sorin ^{[3
]}

Ceausu, Emanoil ^{[5
]}

Ruta, Simona ^{[1
,2
]}

机构：

[1] Carol Davila Univ Med & Pharm, Virol Discipline, 8 Eroilor Sanit Bvd, Bucharest, Romania

[2] Stefan S Nicolau Inst Virol, Dept Emergent Viral Dis, 285 Mihai Bravu Bvd, Bucharest, Romania

[3] NIRDMI Cantacuzino, Mol Epidemiol Lab, 103 Splaiul Independentei Bvd, Bucharest, Romania

[4] Carol Davila Univ Med & Pharm, Dept Microbiol & Epidemiol, Bucharest, Romania

[5] Dr Victor Babes Clin Infect & Trop Dis, 281 Mihai Bravu Bvd, Bucharest, Romania

来源：

ROMANIAN BIOTECHNOLOGICAL LETTERS | 2017年 / 22卷 / 06期

关键词：

chronic hepatitis C; treatment; IP-10; sCD26; IL28B polymorphism; HCV INFECTION; FIBROSIS; PREDICTS; CXCL10; IL28B; INFLAMMATION; RNA;

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The predictive value of two easy-to-determine serum biomarkers: IP-10 (Interferon-gamma inducible protein-10 kD) and sCD26 (soluble CD26) on the virological response of interferon-based therapy was assessed in 119 patients with chronic hepatitis C. Patients who obtained sustained virological response (SVR) had significantly decreased baseline IP-10 concentrations as compared to non-responders (mean IP-10 = 338 +/- 200 pg/mL vs. 472.7 +/- 254 g/mL; p=0.003). Correlation of this inexpensive serological marker with IL2B genotype and baseline HCV viral load can be used in the selection of patients who might benefit from interferon-based therapies, which are currently available in developing economies. On the contrary, there was no correlation between the baseline concentration of sCD26 and the outcome of treatment. IP-10 might be a suitable biomarker to predict virological success after pegylated interferon alpha and ribavirin treatment.

引用

页码：13155 / 13162

页数：8

共 50 条

[41] Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C [J].

Camelia Sultana ;

Gabriela Opri?an ;

Monica Delia Teleman ;

Sorin Dinu ;

HepGen 88/2012 Project Team ;

Cristiana Oprea ;

Mihai Voiculescu ;

Simona Ruta .

World Journal of Gastroenterology, 2016, (37) :8406-8413

[42] Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C [J].

Sultana, Camelia ;

Oprisan, Gabriela ;

Teleman, Monica Delia ;

Dinu, Sorin ;

Oprea, Cristiana ;

Voiculescu, Mihai ;

Ruta, Simona .

WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (37) :8406-8413

[43] Liver Protein Profiling in Chronic Hepatitis C: Identification of Potential Predictive Markers for Interferon Therapy Outcome [J].

Perdomo, Ariel Basulto ;

Ciccosanti, Fabiola ;

Lo Iacono, Oreste ;

Angeletti, Claudio ;

Corazzari, Marco ;

Daniele, Nicola ;

Testa, Angela ;

Pisa, Roberto ;

Ippolito, Giuseppe ;

Antonucci, Giorgio ;

Fimia, Gian Maria ;

Piacentini, Mauro .

JOURNAL OF PROTEOME RESEARCH, 2012, 11 (02) :717-727

[44] Association of Interferon-gamma Induced Protein 10 Promoter Polymorphisms with the Disease Progression of Hepatitis B Virus Infection in Chinese Han Population [J].

Xu, Zhihui ;

Liu, Yan ;

Liu, Liming ;

Li, Xiaodong ;

Bai, Siyu ;

Rong, Yihui ;

Wang, Haibin ;

Mao, Yuanli ;

Xin, Shaojie ;

Xu, Dongping .

PLOS ONE, 2013, 8 (09)

[45] Can Interferon-Gamma or Interferon-Gamma-Induced-Protein-10 Differentiate Tuberculosis Infection and Disease in Children of High Endemic Areas? [J].

Yassin, Mohammed Ahmed ;

Petrucci, Roberta ;

Garie, Kefyalew Taye ;

Harper, Gregory ;

Arbide, Isabel ;

Aschalew, Melkamsew ;

Merid, Yared ;

Kebede, Zelalem ;

Bawazir, Amin Ahmed ;

Abuamer, Nabil Mohamed ;

Cuevas, Luis Eduardo .

PLOS ONE, 2011, 6 (09)

[46] Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C [J].

DeMitri, MS ;

Morsica, G ;

Chen, CH ;

Mele, L ;

Baccarini, P ;

Chianese, R ;

Piccinini, A ;

Lazzarin, A ;

Pisi, E .

ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 29 (03) :255-261

[47] Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis [J].

Kojima, Akira ;

Kakizaki, Satoru ;

Hosonuma, Ken-ichi ;

Yamazaki, Yuichi ;

Horiguchi, Norio ;

Sato, Ken ;

Kitahara, Tokuyuki ;

Mori, Masatomo .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (04) :690-699

[48] Application of Interferon Response-Related Gene Array to the Antiviral Treatment Outcome in Chronic Hepatitis C [J].

Xing Tong-Jing ;

Xv Hong-Tao ;

Zhao Wei ;

Shen Ling ;

Li Hao ;

Cai Ren-Tian .

HEPATO-GASTROENTEROLOGY, 2010, 57 (102-03) :1257-1263

[49] Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1 [J].

Lahrtz, F ;

Piali, L ;

Nadal, D ;

Pfister, HW ;

Spanaus, KS ;

Baggiolini, M ;

Fontana, A .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (10) :2484-2489

[50] TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON ALFA [J].

CIMINO, L ;

NARDONE, G ;

CITARELLA, C ;

PERNA, E ;

CAPUANO, G ;

BUDILLON, G .

ITALIAN JOURNAL OF GASTROENTEROLOGY, 1991, 23 (07) :399-402

← 1 2 3 4 5 →